PlumX Metrics
Embed PlumX Metrics

Post-acute sequelae of COVID-19 (PASC): a meta-narrative review of pathophysiology, prevalence, and management.

SN comprehensive clinical medicine, ISSN: 2523-8973, Vol: 4, Issue: 1, Page: 90
2022
  • 34
    Citations
  • 0
    Usage
  • 77
    Captures
  • 4
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

  • Citations
    34
    • Citation Indexes
      30
    • Policy Citations
      4
      • 4
  • Captures
    77
  • Mentions
    4
    • News Mentions
      4
      • 4

Most Recent News

COVID-19 and the Brain: Understanding the Neurological Effects of the Virus as the Pandemic Evolves

This piece is part of the This Year in Medicine series from our sister site, HCPLive®, and originally appeared there. When the COVID-19 pandemic was

Review Description

Coronavirus Disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Over 220 countries and territories have been affected by this virus, and the infection rate has continued to rise. As patients recover from the virus, many are experiencing lingering symptoms. Understanding the impact of demographics and comorbidities on symptom prevalence, manifestations, and severity is not only relevant during acute infection, it is critical to the clinical management of patients with post-acute sequelae of COVID-19, also known as PASC. Herein, we provide a comprehensive review on the most recent research related to PASC. Specifically, we focus on the description of the disorder itself, compared to acute COVID-19, and which types of patients are most affected by long-term sequelae. Further, we share recommendations for management of the most common complications of PASC.

Bibliographic Details

Munipalli, Bala; Seim, Lynsey; Dawson, Nancy L; Knight, Dacre; Dabrh, Abd Moain Abu

Springer Science and Business Media LLC

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know